ORIGINAL RESEARCH article
Front. Med.
Sec. Nephrology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1644526
This article is part of the Research TopicInnovative Therapeutic Strategies for Chronic Kidney Disease: From Molecular Mechanisms to Clinical PracticeView all 8 articles
Comparative Outcomes of Ureteroscopy and Percutaneous Nephrolithotomy in CKD Patients with Renal Calculi: A Propensity-Matched Cohort Study
Provisionally accepted
- 1Chi Mei Medical Center, Tainan, Taiwan
- 2Taichung Veterans General Hospital, Taichung, Taiwan
- 3Chi Mei Medical Center, Yongkang District, Taiwan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Kidney stones frequently coexist with chronic kidney disease (CKD), sharing common risk factors and leading to adverse outcomes. While percutaneous nephrolithotomy (PCNL) and ureteroscopy (URS) are both effective treatment options, the safety of PCNL has been well-established in CKD patients, whereas the safety profile of URS remains less clear. Methods A retrospective cohort study using the TriNetX database was conducted to compare outcomes in CKD patients undergoing URS or PCNL. Patients aged ≥18 years with a diagnosis of renal stones and CKD were included, excluding those on dialysis. Propensity score matching (PSM) was performed to balance baseline characteristics. The primary outcome was the 5-year rate of major adverse kidney events (MAKE), a composite of mortality, dialysis initiation, and worsened renal function. Secondary outcomes included all-cause mortality and dialysis dependence. Subgroup and sensitivity analyses were performed to ensure robustness. Results Of 5,470 eligible patients, 837 underwent URS and 4,633 underwent PCNL, with 723 patients matched in each group post-PSM. There was no significant difference in MAKE between URS and PCNL (HR 0.93; 95% CI 0.68–1.28; p = 0.6952). All-cause mortality (HR 0.98; 95% CI 0.70–1.36; p = 0.9125) and dialysis dependence (HR 0.57; 95% CI 0.23–1.38; p = 0.2128) were also similar. The limitation of this study is the lack of data on stone size and location. Conclusion In CKD patients with renal stones, URS demonstrated comparable safety and efficacy compared to PCNL, with no significant differences in MAKE, all-cause mortality, or dialysis dependence over 5 years. However, the lack of information regarding stone size, anatomical location, and procedure-specific details (e.g., device use or surgical technique) is a major limitation of our study.
Keywords: CKD, make, PCNL, Renal stone, URS
Received: 10 Jun 2025; Accepted: 22 Sep 2025.
Copyright: © 2025 Min Lin, Chiou and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Min Lin, xxpil305a@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.